2008 Recipients
2008 - Three-Year Award ($600,000)
Keith Ligon, M.D., Ph.D.
Dana-Farber Cancer Institute
Stem and Progenitor Cell Transcription Factor Networks as Therapeutic Targets in Malignant Glioma
John Sampson, M.D., Ph.D.
Duke University Medical Center
Predicting Oncogenic Pathways driving Resistance to an EGFRvIII-targeted Vaccine using Signaling Pathway Gene Signatures
Erwin Van Meir, Ph.D.
Emory University
Mechanism of Action and Exploitation of Secreted Galectin-3 for Malignant Glioma Therapy
Wei Zhang, Ph.D.
The University of Texas M.D. Anderson Cancer Center
Validating the IGFBP2-ILK-NFkB Pathway in Glioma Development and Progression by a Glial Specific Mouse Model
2008 - One-Year Awards ($100,000)
Jef Boeke, Ph.D., D.Sc.
Johns Hopkins University School of Medicine
Retrotransposon Instability in Glioblastoma Multiforme
Joseph Costello, Ph.D.
University of California San Francisco
Deep-Sequencing of Glioblastoma Stem Cell Epigenomes
Calvin Kuo, M.D., Ph.D.
Stanford University School of Medicine
GPCR-Targeted Anti-angiogenic Therapy of Glioblastoma
Yael Mardor, Ph.D.
The Chaim Sheba Medical Center
Convection-Enhanced Delivery of High Viscosity Nano-Particles
Kyle Weaver, M.D.
Vanderbilt University
Biomarker Development using Absolute Copy Number of Methylated Tumor Suppressor Genes in the Plasma of Patients with Malignant Glioma
|